Trademark Overview
On Thursday, October 16, 2025, a trademark application was filed for IXCLERMA with the United States Patent and Trademark Office. The USPTO has given the IXCLERMA trademark a serial number of 79437265. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 20, 2025. This trademark is owned by CELLTRION, INC.. The IXCLERMA trademark is filed in the Pharmaceutical Products category with the following description:
Monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of psoriasis; immunomodulatory pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune diseases.